Literature DB >> 8866683

Alterations in tau protein metabolism during normal aging.

E B Mukaetova-Ladinska1, C R Harrington, M Roth, C M Wischik.   

Abstract

It is unknown whether aging and Alzheimer's disease (AD) are on the same continuum, or whether they are qualitatively distinct. Tau protein has been identified as a major constituent of paired helical filaments (PHFs) and AD is characterised by a major redistribution of the normal tau protein pool into PHFs. Little is known about the changes in tau protein distribution that occur in the course of normal aging. We have examined PHF-bound and normal tau fractions in frontal, temporal, parietal and occipital neocortex, cerebellum, hippocampus and entorhinal cortex in 15 cognitively unimpaired individuals aged 19-88 years at death. Insoluble tau protein in the PHF fraction did not increase with aging in any brain region, despite the appearance of neurofibrillary pathology at low density in the more elderly cases. By contrast, normal tau protein decreased with aging (r = 0.32, p < 0.001), with an average loss of 14% of soluble tau per decade after the age of 20 years. This was unrelated either to neurofibrillary or beta-amyloid pathology. Frontal grey matter and hippocampus were most vulnerable to age-related tau loss, decreasing by as much as 90% in the older subgroup. These findings contrast with those we have previously reported in AD, where the redistribution of tau protein into the PHF-bound fraction was highly correlated with the extent of neurofibrillary pathology, and suggest that the mechanisms of tau loss in aging and AD are distinct. Age-related tau loss may underlie the neuropsychological impairments seen in the non-demented elderly.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8866683     DOI: 10.1159/000106861

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  9 in total

1.  Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease.

Authors:  E B Mukaetova-Ladinska; F Garcia-Siera; J Hurt; H J Gertz; J H Xuereb; R Hills; C Brayne; F A Huppert; E S Paykel; M McGee; R Jakes; W G Honer; C R Harrington; C M Wischik
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  A Quantitative Analysis of Brain Soluble Tau and the Tau Secretion Factor.

Authors:  Pengcheng Han; Geidy Serrano; Thomas G Beach; Richard J Caselli; Junxiang Yin; Ningning Zhuang; Jiong Shi
Journal:  J Neuropathol Exp Neurol       Date:  2017-01-01       Impact factor: 3.685

Review 3.  Epigenetic mechanisms in Alzheimer's disease.

Authors:  Diego Mastroeni; Andrew Grover; Elaine Delvaux; Charisse Whiteside; Paul D Coleman; Joseph Rogers
Journal:  Neurobiol Aging       Date:  2011-04-11       Impact factor: 4.673

4.  Comparison of glucocorticoid receptor and ionized calcium-binding adapter molecule 1 immunoreactivity in the adult and aged gerbil hippocampus following repeated restraint stress.

Authors:  Joon Ha Park; Ki-Yeon Yoo; Choong Hyun Lee; In Hye Kim; Bich Na Shin; Jung Hoon Choi; Jeong Ho Park; In Koo Hwang; Moo-Ho Won
Journal:  Neurochem Res       Date:  2011-03-12       Impact factor: 3.996

Review 5.  Dysfunction of the neurovascular unit in ischemic stroke and neurodegenerative diseases: An aging effect.

Authors:  Wei Cai; Kai Zhang; Peiying Li; Ling Zhu; Jing Xu; Boyu Yang; Xiaoming Hu; Zhengqi Lu; Jun Chen
Journal:  Ageing Res Rev       Date:  2016-09-30       Impact factor: 10.895

6.  Immunoreactivities and levels of mineralocorticoid and glucocorticoid receptors in the hippocampal CA1 region and dentate gyrus of adult and aged dogs.

Authors:  Jung Hoon Choi; In Koo Hwang; Choong Hyun Lee; Dae Won Chung; Ki-Yeon Yoo; Hua Li; Moo-Ho Won; Je Kyung Seong; Yeo Sung Yoon; In Se Lee
Journal:  Neurochem Res       Date:  2007-11-06       Impact factor: 3.996

7.  Tau phosphorylation and μ-calpain activation mediate the dexamethasone-induced inhibition on the insulin-stimulated Akt phosphorylation.

Authors:  Yudong Liu; Ying Su; Shenggang Sun; Tao Wang; Xian Qiao; Xiaoqin Run; Zhihou Liang
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

8.  Diverse, evolving conformer populations drive distinct phenotypes in frontotemporal lobar degeneration caused by the same MAPT-P301L mutation.

Authors:  Nathalie Daude; Chae Kim; Sang-Gyun Kang; Ghazaleh Eskandari-Sedighi; Tracy Haldiman; Jing Yang; Shelaine C Fleck; Erik Gomez-Cardona; Zhuang Zhuang Han; Sergi Borrego-Ecija; Serene Wohlgemuth; Olivier Julien; Holger Wille; Laura Molina-Porcel; Ellen Gelpi; Jiri G Safar; David Westaway
Journal:  Acta Neuropathol       Date:  2020-03-26       Impact factor: 17.088

Review 9.  The physiological roles of tau and Aβ: implications for Alzheimer's disease pathology and therapeutics.

Authors:  Sarah A Kent; Tara L Spires-Jones; Claire S Durrant
Journal:  Acta Neuropathol       Date:  2020-07-29       Impact factor: 15.887

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.